Skip to main content

Dihydroergotamine News

Related terms: Dihydroergotamine Nasal

FDA Approves Trudhesa (dihydroergotamine mesylate) Nasal Spray for the Acute Treatment of Migraine

SEATTLE, Sept. 03, 2021 (GLOBE NEWSWIRE) – Impel NeuroPharma, Inc. (NASDAQ: IMPL), a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from diseases...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Cluster Headaches, Migraine, Headache

Dihydroergotamine patient information at Drugs.com